SHZ · 300246.SZ
Guangdong Biolight Meditech Co., Ltd.
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
Loading market information…
SHZ · 000638.SZ · CNY
Stock price, earnings
Quote as of Apr 15, 2026, 01:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Vanfund Urban Investment and Development Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 88.76% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Vanfund Urban Investment and Development Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Beijing, China, Vanfund Urban Investment and Development Co., Ltd. operates across a diverse range of sectors. The company specializes in creating medical information software specifically for the Chinese market. Beyond its technology ventures, Vanfund also engages in the processing and trading of grain, alongside offering comprehensive medical and health informatization services. Its portfolio further extends to land consolidation and development projects, as well as mining operations. This enterprise was formerly identified as Vanfund Real Estate Co., Ltd., but adopted its current corporate identity in April 2013.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:22 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥12.02-CN¥0.25 (-2.04%)
Guangdong Biolight Meditech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 45.31% below the high.
CN¥22.64-CN¥0.48 (-2.08%)
Guangzhou Jet Bio-Filtration Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 25.96% below the high.
CN¥28.45-CN¥1.46 (-4.88%)
Shaanxi Kanghui Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 39.36% below the high.
CN¥7.31+CN¥1.22 (+20.03%)
Improve Medical Instruments Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.78% below the high.
CN¥3.53-CN¥0.23 (-6.12%)
Chengdu Huasun Technology Group Inc., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 31.46% below the high.
CN¥17.19-CN¥1.05 (-5.76%)
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.11% below the high.
CN¥5.56-CN¥0.19 (-3.3%)
Hubei Guangji Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 46.64% below the high.
CN¥5.98-CN¥0.10 (-1.64%)
Anhui Huangshan Capsule Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 30.63% below the high.
